Achieve Life Sciences (ACHV) Current Leases (2010 - 2026)
Achieve Life Sciences (ACHV) recorded quarterly Current Leases of $51000.0 in Q1 2026, down 16.39% on a QoQ basis from $61000.0 in Q4 2025, and down 10.53% year-over-year from $57000.0 in Q1 2025.
Achieve Life Sciences (ACHV) Current Leases (2010 - 2026) Analysis & Trends
Achieve Life Sciences has disclosed Current Leases across 17 years of filings, most recently posting $51000.0 for Q1 2026.
- Quarterly Current Leases fell 10.53% year-over-year to $51000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $51000.0 (down 10.53% YoY) and the FY2025 annual result came in at $61000.0, up 10.91% from the prior year.
- Current Leases retreated to $51000.0 in Q1 2026, from $61000.0 in the prior quarter.
- Over five years, Current Leases peaked at $63000.0 in Q4 2023 and troughed at $22000.0 in Q3 2024.
- A 5-year average of $51529.4 and a median of $58000.0 in 2022 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2022 — Current Leases slumped 66.67% — and 2025, when it jumped 168.18%.
- Tracing ACHV's Current Leases over 5 years: stood at $58000.0 in 2022, then rose by 8.62% to $63000.0 in 2023, then declined by 12.7% to $55000.0 in 2024, then increased by 10.91% to $61000.0 in 2025, then retreated by 16.39% to $51000.0 in 2026.
- Business Quant data shows ACHV's Current Leases at $51000.0 in Q1 2026, $61000.0 in Q4 2025, and $59000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 42,980.09 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Achieve Life Sciences | 93.71 Mn | 63.22 Mn | - | 51,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51,000.00 |
| Dec 31, 2025 | 61,000.00 |
| Sep 30, 2025 | 59,000.00 |
| Jun 30, 2025 | 58,000.00 |
| Mar 31, 2025 | 57,000.00 |
| Dec 31, 2024 | 55,000.00 |
| Sep 30, 2024 | 22,000.00 |
| Jun 30, 2024 | 37,000.00 |
| Mar 31, 2024 | 53,000.00 |
| Dec 31, 2023 | 63,000.00 |
| Sep 30, 2023 | 61,000.00 |
| Jun 30, 2023 | 60,000.00 |
| Mar 31, 2023 | 58,000.00 |
| Dec 31, 2022 | 58,000.00 |
| Sep 30, 2022 | 23,000.00 |
| Jun 30, 2022 | 41,000.00 |
| Mar 31, 2022 | 59,000.00 |
| Dec 31, 2021 | 69,000.00 |
| Sep 30, 2021 | 69,000.00 |
| Jun 30, 2021 | 68,000.00 |